Extended Screening

Peace of Mind for Planned Pregnancies

Extended Carrier Screening is an important tool for prospective parents to help them determine their risk of having a child affected with a heritable disease. In many cases parents do not have any idea that they are carriers and have no family history or health symptoms due to the rarity of some diseases in the general population. Through Next Generation Sequencing (NGS) we are able to conduct Extended Carrier Screening (ECS), Extended Carrier Screening consists of a large panel that is able to analyse specific genes that are associated with hundreds of autosomal recessive and X-linked disorders to prospective parents in a general mixed population.[1] Paternity For Life offers a comprehensive Extended Carrier Screening test, providing prospective parents with the information they require when planning their pregnancy, it has also been recommended that extended carrier screening is offered to all women when planning a pregnancy, regardless of their geographic origin or family history.[2] Extended Carrier Screening has been shown to detect carriers who would not have been considered candidates for traditional risk-based screening.[3] With a simple mouth swab collection, we are able to test for over 419 genes associated with inherited diseases, including Cystic Fibrosis, Spinal Muscular Atrophy and Fragile X Syndrome. If your gene of interest is not covered on our Extended Carrier Screening panel, please contact our friendly team to assist you in finding the gene test panel that suits your needs.

Why do genetic testing with Paternity For Life?

Approximately 1-2 of every 100 couples within the general population are at risk of being a carrier for an autosomal recessive genetic condition.[5] Extended Carrier Screening for couples who are considering starting a family, aims to identify if each individual may be a carrier for the same autosomal recessive genetic condition. Extended Carrier Screening prior to pregnancy enables couples to learn about their reproductive risk and consider the most complete range of reproductive options, including whether or not to become pregnant, use of advanced reproductive technologies such as preimplantation genetic diagnosis or to use donor gametes. Screening also allows couples to consider prenatal diagnosis and pregnancy management options in the event of an affected fetus. At Paternity For Life we understand the sensitivities surrounding testing and we can assure you we strive to provide all of our patients with the highest level of professionalism, care and compassion. We offer an easy mouth swab collection kit that can be done in the comfort of your home and our laboratory handles your sample from start to finish.

What genetic conditions are tested by the Extended Carrier Screening?

Our Extended Carrier Screening enables detections of single nucleotide variants (SNVs), insertion/deletions (indels), and copy number variants (CNVs) over 419 genes associated with more than 700 unique commonly inherited diseases including the most common forms of inherited deafness, blindness, heart disease, immunodeficiency, and various ataxias, anaemias, and treatable metabolic syndromes. The assay has been developed to match genes targeted by clinical molecular geneticists studying inherited diseases, including genes listed in the NIH Genetic Test Registry. The clinical utility of this panel lies within the scope of pre-marital screening as well as pre-IVF screening. Please see below for a full list of genes covered on our Extended Carrier Screening panel and the associated genetic conditions.

My partner and I don’t have any diseases, how can we pass it on to our children?

An inherited disease is a disease or disorder caused by an abnormality in our DNA which affects cells throughout our body. The result of the abnormality can range from almost indistinguishable through to major problems. More than 6000 disorders are caused by changes in a single gene and are known as monogenic or Mendelian disorders, resulting in disease in about 1 in every 200 births.[4]

What is an autosomal recessive condition?

Diseases are inherited in different ways, but many are inherited in what is called an “autosomal recessive” pattern, meaning that people that have one abnormal mutation will not have symptoms of the disease, rather being a “carrier” of that disease. If two carriers of an autosomal recessive disease have a child there is a 1/4 risk of the child being affected by that disease. To have an autosomal recessive condition, you inherit two affected genes, one from each parent. These conditions are usually passed on by two carriers (biological mother and father). The parents’ health is rarely affected, but they have one affected gene (recessive gene) and one unaffected gene (dominant gene) for the genetic condition. There is a 25% chance of two carriers having an unaffected child with two unaffected genes, a 50% chance of having a child who also is a carrier but is unaffected by the genetic condition, and a 25% chance of having an affected child who inherits the two recessive genes.[6, 7]

What is an X-linked genetic condition?

X-linked genetic conditions, such as Fragile X Syndrome are caused by variants in genes located on the X chromosome. As males only have one X chromosome, they will be more affected by an X-linked condition in comparison to females, who have two X chromosomes. Females are more likely to be an asymptomatic carrier of an X-linked condition.[6] Paternity For Life is able to screen for Fragile X Syndrome. It is an inherited X-linked genetic condition that is known to cause a range of developmental problems (such as cognitive impairment and learning disabilities).[8, 9] It is estimated that only 1 in 4,000 males and 1 in 8,000 females are diagnosed with Fragile X syndrome, although it is a lot more common to be a carrier of the Fragile X Syndrome, with an estimated 1 in 150 females and 1 in 800 males being premutation carriers of the FMR1 gene.[10] Fragile X Syndrome carriers are at risk of passing on the affected FMR1 gene to their children or grandchildren, resulting in Fragile X Syndrome.[10]

We have a family history of a particular disease, should we be tested?

In cases where there is a known family history of a disease, carrier testing is an important tool for family planning and can guide reproductive options. In some cases, prospective parents will discover that they do not carry the familial mutation and therefore have a reduced risk for having a child with the disease.

If our results are negative does that mean our child will not be affected by a disease on this panel?

Genetic tests cannot detect all of the possible gene variants that could cause a disorder. This means that, even if you test negative, there is still a chance of having, or being a carrier of, one or more of the diseases associated with the genes which were tested. This is called Residual Risk. Please contact us for further information.

If my results show that both my partner and I are carriers, what can we do?

If prospective parents are both shown to be carriers of a genetic disorder, couples may choose to use assisted reproductive technologies such as IVF to become pregnant. Paternity For Life can then assist in screening embryos to reduce the risk of having an affected child. Paternity For Life recommends discussing all options with a genetic counsellor.

Ready to take control of your pregnancy?

Paternity For Life aims to educate patients and their families about inherited diseases and their risk of inheritance, to empower them with the knowledge to take control of their health and treatment plans. As each patient’s case is unique, there is no “one size fits all” when it comes to testing. As inherited disease testing and the results from such tests can be complex, we also recommend you seek Genetic Counselling both prior to and after testing to help you understand your results and the implications they may have for both you and your family. If you are ready to proceed with testing, a Testing Request Form can be downloaded from our website. We recommend you book an appointment with your doctor to discuss the testing and have your Request Form signed. You can then head to our website to submit your order and payment. Paternity For Life will then send a testing kit directly to your home address. All that is required for testing is a simple, painless mouth swab. Once we receive your sample we will begin testing. Results are typically available to your doctor within 21 working days.

How to Organise Testing?

  1. Download our request form.
  2. Book an appointment with your doctor or healthcare professional to discuss the testing and have the request form signed.
  3. Head to our simple, easy-to-use order page to order your test.
  4. Paternity For Life will send you a testing kit for collection of your sample.
  5. Your personalised report is issued to your health care provider in 21 working days.
Condition Gene Condition Gene Condition Gene
Achalasia-Addisonianism-Alacrima Syndrome AAAS Ellis-van Creveld Syndrome, EVC2-related EVC2 Congenital Finnish Nephrosis NPHS1
Harlequin ichthyosis ABCA12 Pontocerebellar Hypoplasia, Type 1B EXOSC3 Steroid-Resistant Nephrotic Syndrome NPHS2
Stargardt Disease, Type 1 ABCA4 Retinitis Pigmentosa 25 EYS Congenital Adrenal Hypoplasia, X-linked NR0B1
Progressive Familial Intrahepatic Cholestasis, Type 2 ABCB11 Factor XI deficiency F11 Enhanced S-Cone Syndrome NR2E3
Progressive Familial Intrahepatic Cholestasis, Type 3 ABCB4 Prothrombin deficiency F2 Congenital Insensitivity to Pain with Anhidrosis (CIPA) NTRK1
Pseudoxanthoma elasticum ABCC6 Hemophilia A F8 Ornithine Aminotransferase Deficiency OAT
Familial Hyperinsulinism, ABCC8-Related ABCC8 Hemophilia B F9 Lowe syndrome, X-Linked OCRL
Adrenoleukodystrophy, X-Linked ABCD1 Tyrosinemia, Type I FAH Costeff Syndrome (3-Methylglutaconic Aciduria, Type 3) OPA3
Mitochondrial Complex I Deficiency, ACAD9-Related ACAD9 Retinitis Pigmentosa 28 FAM161A Ornithine Transcarbamylase Deficiency OTC
Medium Chain Acyl-CoA Dehydrogenase Deficiency ACADM Fanconi Anemia, Group A FANCA Phenylketonuria PAH
Short Chain Acyl-CoA Dehydrogenase Deficiency ACADS Fanconi Anemia, Group C FANCC Pantothenate Kinase-Associated Neurodegeneration PANK2
Short/branched chain acyl-CoA dehydrogenase ACADSB Fanconi Anemia, Group G FANCG Pyruvate Carboxylase Deficiency PC
Very Long-Chain Acyl-CoA Dehydrogenase Deficiency ACADVL Fumarase Deficiency FH Propionic Acidemia, PCCA-Related PCCA
Beta-Ketothiolase Deficiency ACAT1 Limb-Girdle Muscular Dystrophy, Type 2I FKRP Propionic Acidemia, PCCB-Related PCCB
Acyl-CoA Oxidase I Deficiency ACOX1 Walker-Warburg Syndrome, FKTN-Related FKTN Usher Syndrome, Type 1F PCDH15
Combined Malonic and Methylmalonic Aciduria ACSF3 Glycogen Storage Disease, Type IA G6PC Pyruvate Dehydrogenase Deficiency, X-Linked PDHA1
Severe Combined Immunodeficiency, ADA-Related ADA Glucose-6-Phosphate Dehydrogenase Deficiency* G6PD Pyruvate Dehydrogenase Deficiency, PDHB-Related PDHB
Ehlers-Danlos Syndrome, Type VIIC ADAMTS2 Glycogen Storage Disease, Type II (Pompe Disease) GAA Prolidase deficiency PEPD
Bilateral Frontoparietal Polymicrogyria ADGRG1 Krabbe Disease GALC Cytochrome-c oxidase deficiency PET100
Aspartylglucosaminuria AGA Galactose epimerase deficiency GALE Peroxisome Biogenesis Disorder 1A (Zellweger) PEX1
Glycogen Storage Disease, Type III (Cori/Forbes) AGL Galactokinase Deficiency (Galactosemia, Type II) GALK1 Peroxisome Biogenesis Disorder 6A (Zellweger) PEX10
Rhizomelic Chondrodysplasia Punctata, Type 3 AGPS Mucopolysaccharidosis, Type IVA GALNS Peroxisome Biogenesis Disorder 3A (Zellweger) PEX12
Hyperoxaluria, Primary, Type 1 AGXT Hyperphosphatemic familial tumoral calcinosis GALNT3 Peroxisome Biogenesis Disorder 5A (Zellweger) PEX2
Autoimmune polyendocrinopathy syndrome, type I AIRE Galactosemia GALT Peroxisome Biogenesis Disorder 4A (Zellweger) PEX6
Sjogren-Larsson Syndrome ALDH3A2 Guanidinoacetate Methyltransferase Deficiency GAMT Rhizomelic Chondrodysplasia Punctata, Type 1 PEX7
Pyridoxine-dependent epilepsy ALDH7A1 Gaucher Disease GBA Glycogen Storage Disease, Type VII PFKM
Hereditary Fructose Intolerance ALDOB Glycogen Storage Disease, Type IV GBE1 Phosphoglycerate Dehydrogenase Deficiency PHGDH
Congenital Disorder of Glycosylation, Type 1C ALG6 Glutaric Acidemia, Type 1 GCDH Multiple congenital anomalies-hypotonia-seizures syndrome 1 PIGN
Alstrom Syndrome ALMS1 Dopa-responsive dystonia GCH1 Polycystic Kidney Disease, Autosomal Recessive PKHD1
Hypophosphatasia, ALPL-Related ALPL Grebe syndrome GDF5 Infantile neuroaxonal dystrophy 1 PLA2G6
Persistent Müllerian duct syndrome type 1 AMH Combined Oxidative Phosphorylation Deficiency 1 GFM1 Congenital Disorder of Glycosylation, Type 1A, PMM2-Related PMM2
Persistent Müllerian duct syndrome type 2 AMHR2 Isolated growth hormone deficiency, Type IA/II GH1 Pyridoxal 5'-phosphate-dependent epilepsy PNPO
Glycine Encephalopathy, AMT-Related AMT Isolated growth hormone deficiency, Type IB GHRHR POLG-Related Disorders POLG
Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma (MEDNIK) AP1S1 Charcot-Marie-Tooth Disease with Deafness, X-Linked GJB1 Xeroderma pigmentosum Variant POLH
Familial Nephrogenic Diabetes Insipidus, AQP2-Related AQP2 Non-Syndromic Hearing Loss (a.k.a. Connexin 26) GJB2 Muscle-Eye-Brain Disease, POMGNT1-Related POMGNT1
Androgen insensitivity syndrome, X-Linked AR Erythrokeratodermia variabilis et progressiva GJB3 Cytochrome P450 oxidoreductase deficiency POR
Argininemia ARG1 Non-Syndromic Hearing Loss (a.k.a. Connexin 30) GJB6 Ceroid Lipofuscinosis, Neuronal, 1 PPT1
Metachromatic Leukodystrophy, ARSA-Related ARSA Fabry Disease GLA Myasthenic syndrome, congenital, 22 PREPL
Mucopolysaccharidosis, Type VI (Maroteaux-Lamy) ARSB Mucopolysaccharidosis, Type IVB / GM1 Gangliosidosis GLB1 Combined Pituitary Hormone Deficiency 2 PROP1
Argininosuccinate Lyase Deficiency ASL Glycine Encephalopathy, GLDC-Related GLDC Arts syndrome, X-Linked PRPS1
Asparagine Synthetase Deficiency ASNS Lethal Congenital Contracture Syndrome 1 GLE1 Metachromatic Leukodystrophy, PSAP-Related PSAP
Canavan Disease ASPA Inclusion Body Myopathy 2 GNE 6-Pyruvoyl-Tetrahydropterin Synthase (PTPS) Deficiency PTS
Citrullinemia, Type 1 ASS1 Mucolipidosis II/IIIA GNPTAB Mitochondrial Myopathy and Sideroblastic Anemia (MLASA1) PUS1
Ataxia-Telangiectasia ATM Mucolipidosis III gamma GNPTG Glycogen Storage Disease, Type V (McArdle Disease) PYGM
Renal Tubular Acidosis and Deafness, ATP6V1B1-Related ATP6V1B1 Mucopolysaccharidosis, Type IIID (Sanfilippo D) GNS Carpenter Syndrome RAB23
Menkes Syndrome, X-Linked ATP7A Geroderma osteodysplastica GORAB Omenn Syndrome, RAG1-Related RAG1
Wilson Disease ATP7B Bernard-Soulier Syndrome, Type A2 GP1BA Omenn Syndrome, RAG2-Related RAG2
Progressive Familial Intrahepatic Cholestasis, Type 1 ATP8B1 Bernard-Soulier Syndrome, Type B GP1BB Congenital Myasthenic Syndrome, RAPSN-Related RAPSN
Alpha-Thalassemia Intellectual Disability Syndrome, X-Linked ATRX Bernard-Soulier Syndrome, Type C GP9 Pontocerebellar Hypoplasia, Type 1 and 6, RARS2-Related RARS2
Bardet-Biedl Syndrome 1 BBS1 Primary Hyperoxaluria, Type 2 GRHPR Leber Congenital Amaurosis, Type RDH12 RDH12
Bardet-Biedl Syndrome 10 BBS10 Leber congenital amaurosis 1 GUCY2D Retinal Dystrophies, RLBP1-Associated RLBP1
Bardet-Biedl Syndrome 12 BBS12 Mucopolysaccharidosis, Type VII GUSB Cartilage-Hair Hypoplasia RMRP
Bardet-Biedl Syndrome 2 BBS2 Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency HADHA Aicardi-Goutieres syndrome, RNASEH2C-related RNASEH2C
Bardet-Biedl Syndrome 4 BBS4 Trifunctional protein deficiency HADHB Leber Congenital Amaurosis 2 RPE65
Bardet-Biedl Syndrome 9 BBS9 Congenital Neutropenia, HAX1-Related HAX1 Ciliopathies, RPGRIP1L-Related RPGRIP1L
Pseudocholinesterase Deficiency BCHE Alpha-Thalassemia HBA1 Juvenile Retinoschisis, X-Linked RS1
Maple Syrup Urine Disease, Type 1A BCKDHA Alpha-Thalassemia HBA2 Dyskeratosis Congenita, RTEL1-Related RTEL1
Maple Syrup Urine Disease, Type 1B BCKDHB Beta-Hemoglobinopathies HBB Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay SACS
GRACILE Syndrome BCS1L Tay-Sachs Disease HEXA MIRAGE syndrome SAMD9
Bloom Syndrome BLM Sandhoff Disease HEXB Aicardi-Goutières Syndrome SAMHD1
Fanconi anemia, Group J BRIP1 Hemochromatosis, Type 1 HFE Shwachman-Diamond syndrome SBDS
Bartter syndrome, Type 4a BSND Hemochromatosis, Type 2A HFE2 Pontocerebellar Hypoplasia, Type 2D SEPSECS
Biotinidase Deficiency BTD Alkaptonuria HGD Alpha-1-Antitrypsin Deficiency SERPINA1
Isolated growth hormone deficiency, Type III, X-linked BTK Mucopolysaccharidosis, Type IIIC (Sanfilippo C) HGSNAT Limb-Girdle Muscular Dystrophy, Type 2D SGCA
Desbuquois dysplasia 1 CANT1 Holocarboxylase Synthetase Deficiency HLCS Limb-Girdle Muscular Dystrophy, Type 2E SGCB
Limb-Girdle Muscular Dystrophy, Type 2A CAPN3 3-Hydroxy-3-Methylglutaryl-Coenzyme A Lyase Deficiency HMGCL Limb-Girdle Muscular Dystrophy, Type 2F SGCD
Catecholaminergic polymorphic ventricular tachycardia CASQ2 Heme Oxygenase-1 Deficiency HMOX1 Limb-Girdle Muscular Dystrophy, Type 2C SGCG
Homocystinuria, CBS-Related CBS Primary Hyperoxaluria, Type 3 HOGA1 Mucopolysaccharidosis, Type IIIA (Sanfilippo A) SGSH
Mental retardation, autosomal recessive 3 CC2D1A Tyrosinemia, Type III HPD Gitelman Syndrome SLC12A3
Usher Syndrome, Type 1D CDH23 Hermansky-Pudlak Syndrome 1 HPS1 Agenesis of the Corpus Callosum with Peripheral Neuropathy (Andermann Syndrome) SLC12A6
Leber Congenital Amaurosis, Type CEP290 CEP290 Hermansky-Pudlak Syndrome 3 HPS3 Salla Disease SLC17A5
Retinitis Pigmentosa 26 CERKL Hermansky-Pudlak syndrome 4 HPS4 Megaloblastic Anemia Syndrome SLC19A2
Cystic Fibrosis CFTR 17-beta hydroxysteroid dehydrogenase 3 deficiency HSD17B3 Carnitine Deficiency SLC22A5
Choroideremia, X-Linked CHM D-Bifunctional Protein Deficiency HSD17B4 Citrullinemia, Type II SLC25A13
Congenital Myasthenic Syndrome, CHRNE-Related CHRNE 3-Beta-Hydroxysteroid Dehydrogenase Type II Deficiency HSD3B2 Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome SLC25A15
Escobar Syndrome CHRNG Hydrolethalus Syndrome HYLS1 Carnitine-acylcarnitine translocase deficiency SLC25A20
Bare Lymphocyte Syndrome, CIITA-Related CIITA Mucopolysaccharidosis, Type II (Hunter Syndrome) IDS Achondrogenesis, Type 1B SLC26A2
Ceroid Lipofuscinosis, Neuronal, 3 CLN3 Mucopolysaccharidosis, Type I (Hurler Syndrome) IDUA Congenital Chloride Diarrhea SLC26A3
Ceroid Lipofuscinosis, Neuronal, 5 CLN5 Severe Combined Immunodeficiency, X-Linked IL2RG Pendred Syndrome SLC26A4
Ceroid Lipofuscinosis, Neuronal, 6 CLN6 Glanzmann thrombasthenia ITGB3 Autism Spectrum, Epilepsy and Arthrogryposis SLC35A3
Ceroid Lipofuscinosis, Neuronal, 8 (a.ka. Northern Epilepsy) CLN8 Isovaleric Acidemia IVD Glycogen Storage Disease, Type IB SLC37A4
Usher Syndrome, Type 3 CLRN1 Congenital Hyperinsulinism, KCNJ11-Related KCNJ11 Acrodermatitis Enteropathica SLC39A4
Achromatopsia, CNGA3-Related CNGA3 LAMA2-related Muscular Dystrophy LAMA2 Cystinuria, Type A SLC3A1
Achromatopsia, CNGB3-Related CNGB3 Herlitz Junctional Epidermolysis Bullosa, LAMA3-Related LAMA3 Oculocutaneous albinism, Type 4 SLC45A2
Fibrochondrogenesis type 2 COL11A2 Herlitz Junctional Epidermolysis Bullosa, LAMB3-Related LAMB3 Corneal Dystrophy and Perceptive Deafness SLC4A11
Alport Syndrome, COL4A3-Related COL4A3 Herlitz Junctional Epidermolysis Bullosa, LAMC2-Related LAMC2 Creatine Transporter Defect (Cerebral Creatine Deficiency Syndrome 1, X-Linked) SLC6A8
Alport Syndrome, COL4A4-Related COL4A4 Leber Congenital Amaurosis, Type LCA5 LCA5 Lysinuric Protein Intolerance SLC7A7
Alport Syndrome, X-Linked COL4A5 Familial Hypercholesterolemia, LDLR-Related LDLR Cystinuria, Type B SLC7A9
Dystrophic Epidermolysis Bullosa, COL7A1-Related COL7A1 Familial Hypercholesterolemia, LDLRAP1-Related LDLRAP1 Schimke Immunoosseous Dysplasia SMARCAL1
Carbamoyl Phosphate Synthetase I Deficiency CPS1 Leydig cell hypoplasia LHCGR Spinal Muscular Atrophy SMN1
Carnitine Palmitoyltransferase IA Deficiency CPT1A Stuve-Wiedemann Syndrome LIFR Niemann-Pick Disease, Types A/B SMPD1
Carnitine Palmitoyltransferase II Deficiency CPT2 Lysosomal Acid Lipase Deficiency LIPA 5-alpha reductase deficiency SRD5A2
Leber congenital amaurosis 8 CRB1 Woolly Hair/Hypotrichosis Syndrome LIPH GM3 synthase deficiency ST3GAL5
Cystinosis CTNS Deafness, Autosomal Recessive 77 LOXHD1 Lipoid Congenital Adrenal Hyperplasia STAR
Papillon-Lefevre Syndrome CTSC Lipoprotein Lipase Deficiency LPL Deafness, autosomal recessive 16 STRC
Ceroid Lipofuscinosis, Neuronal, 10 (CLN10 Disease) CTSD Leigh Syndrome, French-Canadian Type LRPPRC Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria) SUCLA2
Pycnodysostosis CTSK Chediak-Higashi syndrome LYST Multiple Sulfatase Deficiency SUMF1
Chronic Granulomatous Disease, CYBA-Related CYBA Alpha-Mannosidosis MAN2B1 Leigh Syndrome SURF1
Chronic Granulomatous Disease, X-Linked CYBB Hypermethioninemia MAT1A Tyrosinemia, Type II TAT
Congenital Adrenal Hyperplasia, 11-beta-hydroxylase-deficient CYP11B1 3-Methylcrotonyl-CoA Carboxylase 1 Deficiency MCCC1 Osteopetrosis, Infantile Malignant, TCIRG1-Related TCIRG1
Corticosterone Methyloxidase Deficiency CYP11B2 3-Methylcrotonyl-CoA Carboxylase 2 Deficiency MCCC2 Hereditary Spastic Paraparesis, Type 49 TECPR2
Congenital Adrenal Hyperplasia, 17-Alpha-Hydroxylase Deficiency CYP17A1 Mucolipidosis, Type IV MCOLN1 Hemochromatosis, Type 3, TFR2-Related TFR2
Aromatase Deficiency CYP19A1 RETT Syndrome MECP2 Lamellar Ichthyosis, Type 1 TGM1
Primary Congenital Glaucoma CYP1B1 Microcephaly, postnatal progressive, with seizures and brain atrophy MED17 Segawa Syndrome, TH-Related TH
Congenital Adrenal Hyperplasia, 21-hydroxylase-deficient CYP21A2 Familial Mediterranean Fever MEFV Deafness, autosomal dominant 36, autosomal recessive 7 TMC1
Cerebrotendinous Xanthomatosis CYP27A1 Spondylothoracic Dysostosis, MESP2-Related MESP2 Joubert Syndrome 2 / Meckel Syndrome 2 TMEM216
Vitamin D-dependent rickets type 1A CYP27B1 Ceroid Lipofuscinosis, Neuronal, 7 MFSD8 Congenital hypothyroidism TPO
Maple Syrup Urine Disease, Type 2 DBT Bardet-Biedl Syndrome 6 MKKS Ceroid Lipofuscinosis, Neuronal, 2 TPP1
Severe Combined Immunodeficiency, Type Athabaskan DCLRE1C Meckel-Gruber Syndrome, Type 1 MKS1 Aicardi-Goutieres Syndrome, TREX1-related TREX1
Xeroderma Pigmentosum Group E DDB2 Megalencephalic Leukoencephalopathy with Subcortical Cysts MLC1 Bardet-Biedl syndrome 11 TRIM32
Smith-Lemli-Opitz Syndrome DHCR7 Malonyl-CoA decarboxylase deficiency MLYCD Mulibrey nanism syndrome TRIM37
Retinitis Pigmentosa 59 DHDDS Methylmalonic Aciduria, MMAA-Related MMAA Acute Infantile Liver Failure, TRMU-Related TRMU
Dyskeratosis congenita, X-Linked DKC1 Methylmalonic Aciduria, MMAB-Related MMAB Pontocerebellar hypoplasia TSEN54
Dihydrolipoamide Dehydrogenase Deficiency DLD Methylmalonic Aciduria and Homocystinuria, Type cblC MMACHC Combined Oxidative Phosphorylation Deficiency 3 TSFM
Duchenne/Becker Muscular Dystrophy DMD Methylmalonic Aciduria and Homocystinuria, Type cblD MMADHC Congenital hypothyroidism TSHB
Ciliary Dyskinesia, Primary 3 DNAH5 Molybdenum cofactor deficiency MOCS1 Hypothyroidism, congenital, nongoitrous, 1 TSHR
Ciliary Dyskinesia, Primary 1 DNAI1 Congenital Disorder of Glycosylation, Type 1B MPI Tricho-Hepato-Enteric Syndrome TTC37
Ciliary Dyskinesia, Primary 9 DNAI2 Congenital Amegakaryocytic Thrombocytopenia MPL Familial dilated cardiomyopathy TTN
Ciliary Dyskinesia, Primary, 16 DNAL1 Hepatocerebral Mitochondrial DNA Depletion Syndrome, MPV17-Related MPV17 Ataxia with Vitamin E Deficiency TTPA
Congenital Myasthenic Syndrome, DOK7-Related DOK7 Ataxia-telangiectasia-like disorder 1 MRE11 Myoneurogastrointestinal Encephalopathy (MNGIE) TYMP
Dihydropyrimidine Dehydrogenase Deficiency DPYD Homocystinuria due to Deficiency of MTHFR MTHFR Oculocutaneous Albinism, Type 1 TYR
Limb-Girdle Muscular Dystrophy, Type 2B DYSF Myotubular Myopathy, X-Linked MTM1 Oculocutaneous albinism, Type 3 TYRP1
Hypohidrotic Ectodermal Dysplasia, X-Linked EDA Homocystinuria, Type cblE MTRR Crigler-Najjar Syndrome UGT1A1
Hypohidrotic Ectodermal Dysplasia EDAR Abetalipoproteinemia MTTP Beta-ureidopropionase deficiency UPB1
Wolcott-Rallison Syndrome EIF2AK3 Methylmalonic Aciduria, Type mut(0) MUT Usher Syndrome, Type 1C USH1C
Leukoencephalopathy with Vanishing White Matter EIF2B5 Deafness, autosomal recessive, 3 MYO15A Usher Syndrome, Type 2A USH2A
Dysautonomia, familial ELP1 Usher Syndrome, Type 1B MYO7A Choreo-acanthocytosis VPS13A
Emery-Dreifuss Muscular Dystrophy 1, X-Linked EMD Mucopolysaccharidosis, Type IIIB (Sanfilippo B) NAGLU Cohen Syndrome VPS13B
Xeroderma Pigmentosum Group D ERCC2 N-acetylglutamate Synthase Deficiency NAGS Congenital Neutropenia, VPS45-Related VPS45
Xeroderma Pigmentosum Group B ERCC3 Nijmegen Breakage Syndrome NBN Pontocerebellar Hypoplasia, Type 2E VPS53
Xeroderma Pigmentosum Group F ERCC4 Charcot-Marie-Tooth Disease type 4D NDRG1 Pontocerebellar Hypoplasia, Type 1A VRK1
Xeroderma pigmentosum Group G ERCC5 Mitochondrial Complex I Deficiency, NDUFAF5-Related NDUFAF5 Microphthalmia/Anophthalmia, VSX2-Related VSX2
Cockayne syndrome, type B ERCC6 Mitochondrial complex I deficiency NDUFS4 Von Willebrand disease VWF
Cockayne syndrome, type A ERCC8 Mitochondrial Complex I Deficiency, NDUFS6-Related NDUFS6 Wiskott-Aldrich syndrome, X-Linked WAS
Roberts Syndrome ESCO2 Nemaline Myopathy, NEB-Related NEB Progressive Pseudorheumatoid Dysplasia WISP3
Glutaric Acidemia, Type 2A ETFA Sialidosis NEU1 Odonto-Onycho-Dermal Dysplasia / Schopf-Schulz-Passarge Syndrome WNT10A
Glutaric Acidemia, Type 2B ETFB Hydatidiform Mole, Recurrent NLRP7 Werner Syndrome WRN
Glutaric Acidemia, Type 2C ETFDH Niemann-Pick Disease, Type C1/D NPC1 Xeroderma pigmentosum Group A XPA
Ethylmalonic Encephalopathy ETHE1 Niemann-Pick Disease, Type C2 NPC2 Xeroderma Pigmentosum Group C XPC
Ellis-van Creveld Syndrome, EVC-Related EVC Juvenile Nephronophthisis NPHP1 Spastic Paraplegia Type 15 ZFYVE26

Technical Information

Testing targets specific gene mutations and does not detect mutations that are outside of the targeted area. Testing does not completely sequence every exon of each one of the genes. For Ion Torrent sequencing, the limit of detection is 5% at 500X coverage and 10% at 200X coverage. The limit of detection for sequencing is ~1%. For medical practitioners seeking further technical information regarding the assay, please contact Paternity For Life. For medical practitioners seeking further technical information regarding the assay, please contact Paternity For Life.

The Extended Carrier Screening Panel provides comprehensive coverage of common and rare variants to help achieve higher per-disorder detection rate. The panel targets >14,000 amplicons that cover all coding regions of 420 target genes, including intron/exon boundaries, to genotype more than 28,000 SNVs and indels from the ClinVar archive of human variation. The panel also provides robust targeting for CNV analysis to maximise carrier status detection. Genetic variants for a number of the most prevalent yet serious disorders can be difficult to resolve by NGS assays, and so separate additional stand-alone tests are often required. The Extended Carrier Screening Panel consolidates such stand-alone assays into a single assay, including difficult-to-sequence genes, such as SMN1 for spinal muscular atrophy, GBA for Gaucher disease, CYP21A2 for 21-hydroxylase deficient congenital adrenal hyperplasia, and HBA1 and HBA2 for alpha thalassemia.

References

  1. Nijmeijer, S., Conijn, T., Lakeman, P., Henneman, L., Wijburg, F., & Haverman, L. (2019). Attitudes of the general population towards preconception expanded carrier screening for autosomal recessive disorders including inborn errors of metabolism. Molecular Genetics And Metabolism, 126(1), 14-22. doi: 10.1016/j.ymgme.2018.12.004
  2. Genetic carrier screening. (2019). Retrieved 21 May 2021, from https://ranzcog.edu.au/RANZCOG_SITE/media/RANZCOG-MEDIA/Women%27s%20Health/Statement%20and%20guidelines/Clinical-Obstetrics/Genetic-carrier-screening(C-Obs-63)New-March-2019_1.pdf?ext=.pdf
  3. Lazarin, G., Haque, I., Nazareth, S., Iori, K., Patterson, A., & Jacobson, J. et al. (2012). An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals. Genetics In Medicine, 15(3), 178-186. doi: 10.1038/gim.2012.114
  4. Sateesh, M. (2008). Bioethics and biosafety. New Delhi: I.K. International Publishing House.
  5. Ropers, H. (2012). On the future of genetic risk assessment. Journal Of Community Genetics, 3(3), 229-236. doi: 10.1007/s12687-012-0092-2\
  6. Autosomal recessive inheritance pattern. (2021). Retrieved 14 May 2021, from https://www.mayoclinic.org/autosomal-recessive-inheritance-pattern/img-20007457
  7. Genetics, H., & Conditions, I. (2021). What are the different ways a genetic condition can be inherited?: MedlinePlus Genetics. Retrieved 14 May 2021, from https://medlineplus.gov/genetics/understanding/inheritance/inheritancepatterns/
  8. Garber, K., Visootsak, J., & Warren, S. (2008). Fragile X syndrome. European Journal Of Human Genetics, 16(6), 666-672. doi: 10.1038/ejhg.2008.6
  9. Fragile X syndrome: MedlinePlus Genetics. (2021). Retrieved 19 May 2021, from https://medlineplus.gov/genetics/condition/fragile-x-syndrome
  10. Fragile X syndrome | Betterhealth.vic.gov.au. (2021). Retrieved 19 May 2021, from https://www.betterhealth.vic.gov.au/health/ConditionsAndTreatments/fragile-x-syndrome